Results 131 to 140 of about 23,942 (228)
Our findings indicate that a pediatric/AYA‐specific targeted panel deployed in a hospital can deliver rapid, clinically actionable molecular insights with high diagnostic and prognostic yield. This complements larger sequencing platforms by offering speed, focused content, and easier interpretation.
Masato Kojima +8 more
wiley +1 more source
Updated nomenclature for human and mouse neurofibromatosis type 1 genes [PDF]
Anastasaki, Corina +3 more
core +2 more sources
Functional regulation of the Neurofibromatosis 2 tumor suppressor merlin [PDF]
Neurofibromatosis 2 (NF2) is an autosomal dominant disorder manifested by the formation of multiple benign tumors of the nervous system. Affected individuals typically develop bilateral vestibular schwannomas which lead to deafness and balance disorders.
Pehrsson, Minja
core
Systematic genetic screening in a prospective group of Danish patients with pheochromocytoma
Morten Steen Svarer Hansen,1 Niels Jacobsen,1 Anja Lisbeth Frederiksen,2 Lars Lund,3 Marianne Skovsager Andersen,1 Dorte Glintborg1 1Department of Endocrinology and Metabolism, 2Department of Clinical Genetics, 3Department of Urology, Odense University ...
Hansen MSS +5 more
doaj
Collecting duct carcinoma (CDC) of the kidney is a rare type of renal cell carcinoma. It is an aggressive tumor with a poor prognosis and limited treatment options. A 67-year-old man, during evaluation for hematuria, loss of appetite and weight loss, and
Arathi Edayattil +5 more
doaj +1 more source
The RASopathies, collectively, are a spectrum of genetic syndromes caused by mutations in genes involved in the RAS/ mitogen-activated protein kinase (MAPK) pathway, including but not limited to PTPN11, NRAS, KRAS, HRAS, BRAF, and MAP2K1.
Margarita Dionysiou +7 more
doaj +1 more source
A relevant proportion of malignancies predominantly or exclusively affecting women, including breast and gynecologic cancers, is attributable to hereditary tumor syndromes, profoundly impacting cancer risk, prognosis, and therapeutic management.
Annika Krückel +9 more
doaj +1 more source
The Neurofibromatosis Type 2 Gene Is Mutated in Perineurial Cell Tumors [PDF]
Jerzy Lasota +5 more
openaire +1 more source
KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth [PDF]
Anastasaki, Corina +2 more
core +3 more sources
Ossification of Mandibular Central Giant Cell Granuloma (CGCG) in Neurofibromatosis Type 1 Patients. [PDF]
Friedrich RE +3 more
europepmc +1 more source

